Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$140,000.00
Apr 1, 2012
Advancing Tumour Infiltrating Lymphocyte Therapy for Ovarian Cancer to the Clinic
$60,000.00
Apr 1, 2012
Gene Researcher for a Week Program
$513,029.00
Apr 1, 2012
Designing Amphiphilic Polymeric Carriers of DNA for Gene Therapy
$132,604.00
Apr 1, 2012
Improving quality and accessibility of mental health services for older adults: Novel strategies in the delivery of Cognitive Behaviour Therapy for treatment of depression
$349,137.00
Apr 1, 2012
Modifying Gene Expression with Synthetic Nucleic Acid Therapeutics
$845,827.00
Apr 1, 2012
Predicting long-term success on antiretroviral therapy among individuals failing first-line treatment in Uganda
$360,417.00
Apr 1, 2012
Midlife Women with MDD: The Effects of Rapid Tryptophan or Phenylalanine/tyrosine Depletions on Mood and Thermoregulation in Depressed Subjects responsive to Estrogen Therapy.
$636,768.00
Apr 1, 2012
Molecular Targeting of Critical Domains of AHI-1 Oncoprotein in Chronic Myeloid Leukemia Stem Cells Resistant to Current Tyrosine Kinase Inhibitor Therapy
$415,128.00
Apr 1, 2012
Enzyme Enhancement Therapy for GM1 gangliosidosis
$112,500.00
Apr 1, 2012
cAMP-Dependent gene transactivation: a novel mechanism underlying the anti-inflammatory activity of PDE4 inhibitors in COPD.